ARTICLE | Company News
Gilead sales and marketing update
April 18, 2016 7:00 AM UTC
Germany’s Institute for Quality and Efficiency in Health Care (IQWiG) issued a dossier of early benefit assessment for Genvoya tenofovir alafenamide fumarate (TAF)/elvitegravir/cobicistat/emtricitabi...